AUSTIN, Texas, Aug. 31, 2015 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that management will be participating in the following investment conferences:
- Wells Fargo Healthcare Conference at the Hyatt Regency in Boston – Management will be presenting at 2:55 PM Eastern Time on Wednesday, September 9, 2015
- Credit Suisse Small & Mid Cap Conference at the Waldorf Astoria in New York – Management will be presenting at 9:30 AM Eastern Time on Wednesday, September 16, 2015
About LDR Holding Corporation
LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. LDR's primary products are based on its exclusive VerteBRIDGE® fusion and Mobi® non-fusion technology platforms and are designed for applications in the cervical and lumbar spine. These technologies are designed to enable products that are less invasive, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. In August 2013, LDR received approval from the U.S. Food and Drug Administration (FDA) for the Mobi-C® cervical disc replacement device, the first and only cervical disc replacement device to receive FDA approval to treat both one-level and two-level cervical disc disease. For more information regarding LDR Holding, visit www.ldr.com.
CONTACT: Robert McNamara Executive Vice President and Chief Financial Officer LDR Holding Corporation 512-344-3333 Matthew Norman Director, Investor Relations LDR Holding Corporation 512-344-3408Source:LDR Holding Corporation